Search Results - Katharina Modelska

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Tibolone for Postmenopausal Women: Systematic Review of Randomized Trials

    Tibolone for Postmenopausal Women: Systematic Review of Randomized Trials by Katharina Modelska, Steven R. Cummings

    Published 2002
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Roxadustat versus placebo for patients with lower‐risk myelodysplastic syndrome: MATTERHORN phase 3, double‐blind, randomized controlled trial

    Roxadustat versus placebo for patients with lower‐risk myelodysplastic syndrome: MATTERHORN phase 3, double‐blind, randomized controlled trial by Moshe Mittelman, David H. Henry, John A. Glaspy, Anıl Tombak, Rosemary Harrup, Inho Kim, Krzysztof Mądry, Barbara Grabowska, Tyson Lee, Katharina Modelska

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer

    Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer by Maha Hussain, Karim Fizazi, Fred Saad, Per Rathenborg, Neal D. Shore, Ubirajara Ferreira, Petro Ivashchenko, Eren Demirhan, Katharina Modelska, De Phung, Andrew Krivoshik, Cora N. Sternberg

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Roxadustat for the treatment of anemia in patients with <scp>lower‐risk</scp> myelodysplastic syndrome: Open‐label, dose‐selection, lead‐in stage of a phase 3 study

    Roxadustat for the treatment of anemia in patients with <scp>lower‐risk</scp> myelodysplastic syndrome: Open‐label, dose‐selection, lead‐in stage of a phase 3 study by David H. Henry, John A. Glaspy, Rosemary Harrup, Moshe Mittelman, Amy Zhou, Hetty E. Carraway, Charles W. Bradley, Gopal Saha, Katharina Modelska, Pamela Bartels, Robert Leong, Kin‐Hung P. Yu

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    A phase III, randomized, double-blind, placebo (PBO)-controlled study of enzalutamide (ENZA) in men with nonmetastatic (M0) castration-resistant prostate cancer (CRPC): Results of PROSPER by age and region

    A phase III, randomized, double-blind, placebo (PBO)-controlled study of enzalutamide (ENZA) in men with nonmetastatic (M0) castration-resistant prostate cancer (CRPC): Results of... by Karim Fizazi, Maha Hussain, Fred Saad, Neal D. Shore, Ugo De Giorgi, Eleni Efstathiou, Ubirajara Ferreira, Petro Ivashchenko, Katarzyna Madziarska, Mohammed Al-Adhami, Katharina Modelska, D. Phung, Joyce Steinberg, Cora N. Sternberg

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer

    Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer by Cora N. Sternberg, Karim Fizazi, Fred Saad, Neal D. Shore, Ugo De Giorgi, David F. Penson, Ubirajara Ferreira, Eleni Efstathiou, Katarzyna Madziarska, Michael Paul Kolinsky, Daniel de Iracema Gomes Cubero, Bettina Noerby, Fabian Zohren, Xun Lin, Katharina Modelska, Jennifer Sugg, Joyce Steinberg, Maha Hussain

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: